Business
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
SHANGHAI, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, issued a positive profit forecast for 2025, citing stronger-than-expected revenue growth and its first year of full profitability, underscoring the commercial viability of its “AI + chronic care services” model. In a filing released on January 25, the company said it expects full-year revenue for 2025 to reach between RMB 3.5 billio
About this update from Fangzhou Inc.
[{"type":"image","alt":"Fangzhou Inc.","displaySize":"","headline":null,"caption":"Fangzhou Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3I4M1onr9I9LGQ_MtZRvAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6","width":300,"height":95}},"lazy":false},{"type":"text","content":"SHANGHAI, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, issued a positive profit forecast for 2025, citing stronger-than-expected revenue growth and its first year of full profitability, underscoring the commercial viability of its “AI + chronic care services” model.","length":377,"tagName":"p"},{"type":"text","content":"In a filing released on January 25, the company said it expects full-year revenue for 2025 to reach between RMB 3.5 billion and RMB 3.55 billion, representing year-on-year growth of approximately 30%. Fangzhou also forecast a net profit of RMB 7 million to RMB 10 million, marking a transition to comprehensive profitability after achieving adjusted profitability in 2024.","length":372,"tagName":"p"},{"type":"text","content":"The company attributed the revenue increase primarily to the continued expansion of its chronic disease management services built around trusted doctor–patient relationships, as well as the upgrading of its platform through AI technologies. These factors have attracted a growing number of physicians and patients, driving sustained growth in its consumer-facing business. The turnaround to profitability was also supported by higher revenue scale and a reduction in equity-settled and share-based payments.","length":507,"tagName":"p"},{"type":"text","content":"Fangzhou said the earnings improvement reflects a qualitative shift in its business fundamentals, validating the long-term sustainability of its chronic disease management model. The Company operates one of China’s largest “AI + chronic disease management” platforms, benefiting from rising healthcare demand amid an aging population and increasing preference for accessible, technology-enabled medical services.","length":412,"ta...